BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36330456)

  • 1. Advances in the Diagnosis, Monitoring, and Progression of Oral Cancer through Saliva: An Update.
    Rodríguez-Molinero J; Del Carmen Migueláñez-Medrán B; Delgado-Somolinos E; Carreras-Presas CM; López-Sánchez AF
    Biomed Res Int; 2022; 2022():2739869. PubMed ID: 36330456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Salivary Biomarkers in Oral Cancer Detection.
    Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
    Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis.
    Umapathy VR; Natarajan PM; Swamikannu B
    Molecules; 2023 Jul; 28(13):. PubMed ID: 37446943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shaping the future of oral cancer diagnosis: advances in salivary proteomics.
    Barros O; D'Agostino VG; Lara Santos L; Vitorino R; Ferreira R
    Expert Rev Proteomics; 2024 Apr; 21(4):149-168. PubMed ID: 38626289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions.
    de Jong EP; Xie H; Onsongo G; Stone MD; Chen XB; Kooren JA; Refsland EW; Griffin RJ; Ondrey FG; Wu B; Le CT; Rhodus NL; Carlis JV; Griffin TJ
    PLoS One; 2010 Jun; 5(6):e11148. PubMed ID: 20567502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Salivary Proteomics for Oral Cancer Screening.
    Li Q; Ouyang X; Chen J; Zhang P; Feng Y
    Curr Issues Mol Biol; 2020; 37():47-56. PubMed ID: 31950916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary biomarkers for oral cancer and pre-cancer screening: a review.
    Kaur J; Jacobs R; Huang Y; Salvo N; Politis C
    Clin Oral Investig; 2018 Mar; 22(2):633-640. PubMed ID: 29344805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of saliva for early detection of oral cancer: a pilot study.
    Szanto I; Mark L; Bona A; Maasz G; Sandor B; Gelencser G; Turi Z; Gallyas F
    Technol Cancer Res Treat; 2012 Apr; 11(2):181-8. PubMed ID: 22335413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary biomarkers in cancer.
    Eftekhari A; Maleki Dizaj S; Sharifi S; Salatin S; Khalilov R; Samiei M; Zununi Vahed S; Ahmadian E
    Adv Clin Chem; 2022; 110():171-192. PubMed ID: 36210075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivaomics in oral cancer.
    Aro K; Kaczor-Urbanowicz K; Carreras-Presas CM
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):91-97. PubMed ID: 30507690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of salivary metabolomic biomarkers for oral cancer screening.
    Ishikawa S; Sugimoto M; Kitabatake K; Sugano A; Nakamura M; Kaneko M; Ota S; Hiwatari K; Enomoto A; Soga T; Tomita M; Iino M
    Sci Rep; 2016 Aug; 6():31520. PubMed ID: 27539254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.
    Hsiao YC; Chi LM; Chien KY; Chiang WF; Chen SF; Chuang YN; Lin SY; Wu CC; Chang YT; Chu LJ; Chen YT; Chia SL; Chien CY; Chang KP; Chang YS; Yu JS
    Mol Cell Proteomics; 2017 Oct; 16(10):1829-1849. PubMed ID: 28821604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
    Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
    Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
    Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
    J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva diagnostics - Current views and directions.
    Kaczor-Urbanowicz KE; Martin Carreras-Presas C; Aro K; Tu M; Garcia-Godoy F; Wong DT
    Exp Biol Med (Maywood); 2017 Mar; 242(5):459-472. PubMed ID: 27903834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of interleukins-6 and 8 in saliva as potential biomarkers of oral pre-malignant lesion and oral carcinoma: A breakthrough in salivary diagnostics in Pakistan.
    Khyani IAM; Qureshi MA; Mirza T; Farooq MU
    Pak J Pharm Sci; 2017 May; 30(3):817-823. PubMed ID: 28653927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective early detection of oral cancer using a simple and inexpensive point of care device in oral rinses.
    Franzmann EJ; Donovan MJ
    Expert Rev Mol Diagn; 2018 Oct; 18(10):837-844. PubMed ID: 30221559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics study of oral cancers.
    Chen X; Yu D
    Metabolomics; 2019 Feb; 15(2):22. PubMed ID: 30830419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.